AAPL317.31+1.99 (+0.63%) ▲|ABBV248.00-0.08 (-0.03%) ▼|ABT92.11-1.82 (-1.94%) ▼|ACN138.52+3.29 (+2.43%) ▲|ADBE230.61+6.97 (+3.12%) ▲|AMAT575.39-27.11 (-4.50%) ▼|AMD534.39-23.50 (-4.21%) ▼|AMGN360.45-2.94 (-0.81%) ▼|AMT169.50+0.91 (+0.54%) ▲|AMZN247.31+1.97 (+0.80%) ▲|AVGO384.05-15.92 (-3.98%) ▼|AXP354.43+3.85 (+1.10%) ▲|BA215.51-6.77 (-3.05%) ▼|BAC59.50-0.17 (-0.28%) ▼|BKNG175.80-2.59 (-1.45%) ▼|BLK1,031.56-4.55 (-0.44%) ▼|BMY59.34+1.76 (+3.06%) ▲|BNY151.27-0.65 (-0.43%) ▼|BRK-B496.85+3.14 (+0.64%) ▲|C140.71-0.08 (-0.06%) ▼|CAT931.47-20.94 (-2.20%) ▼|CL93.21+0.97 (+1.05%) ▲|CMCSA23.97+0.40 (+1.70%) ▲|COF203.02+1.50 (+0.74%) ▲|COP112.85+3.81 (+3.49%) ▲|COST926.43+10.18 (+1.11%) ▲|CRM171.22+7.90 (+4.84%) ▲|CSCO119.25-2.06 (-1.70%) ▼|CVS105.90+1.75 (+1.68%) ▲|CVX182.20+5.80 (+3.29%) ▲|DE585.64-1.22 (-0.21%) ▼|DHR200.16+1.11 (+0.56%) ▲|DIS96.00+0.38 (+0.40%) ▲|DUK126.86+1.38 (+1.10%) ▲|EMR135.38-3.50 (-2.52%) ▼|FDX313.74-0.95 (-0.30%) ▼|GD372.78-2.28 (-0.61%) ▼|GE353.42-5.85 (-1.63%) ▼|GEV1,042.60-48.97 (-4.49%) ▼|GILD131.40+1.57 (+1.21%) ▲|GM76.72-1.13 (-1.45%) ▼|GOOG350.67-4.36 (-1.23%) ▼|GOOGL352.51-4.67 (-1.31%) ▼|GS1,045.91-9.27 (-0.88%) ▼|HD337.11-6.19 (-1.80%) ▼|HON222.25-4.17 (-1.84%) ▼|IBM290.23+2.67 (+0.93%) ▲|INTC103.12-6.72 (-6.12%) ▼|INTU289.76+14.80 (+5.38%) ▲|ISRG407.12+0.34 (+0.08%) ▲|JNJ257.77+0.79 (+0.31%) ▲|JPM334.53-1.94 (-0.58%) ▼|KO84.25+0.76 (+0.91%) ▲|LIN524.06-5.73 (-1.08%) ▼|LLY1,181.87-6.71 (-0.56%) ▼|LMT520.68-2.54 (-0.49%) ▼|LOW207.70-3.93 (-1.86%) ▼|LRCX329.92-20.41 (-5.83%) ▼|MA537.70+10.96 (+2.08%) ▲|MCD272.61-1.99 (-0.72%) ▼|MDLZ59.86+1.03 (+1.75%) ▲|MDT83.57-0.30 (-0.36%) ▼|META656.73-12.48 (-1.86%) ▼|MMM157.70+0.18 (+0.11%) ▲|MO71.87+0.08 (+0.11%) ▲|MRK124.03+0.49 (+0.40%) ▲|MS221.09-1.19 (-0.54%) ▼|MSFT390.99+5.89 (+1.53%) ▲|MU937.00-42.30 (-4.32%) ▼|NEE88.38+0.42 (+0.48%) ▲|NFLX73.83+0.46 (+0.63%) ▲|NKE43.76-0.61 (-1.37%) ▼|NOW111.26+3.55 (+3.30%) ▲|NVDA203.53-7.43 (-3.52%) ▼|ORCL131.54-9.10 (-6.47%) ▼|PEP138.49+1.11 (+0.81%) ▲|PFE24.48+0.31 (+1.28%) ▲|PG148.37+1.33 (+0.90%) ▲|PLTR130.04+3.25 (+2.56%) ▲|PM180.19-1.43 (-0.79%) ▼|QCOM183.98-5.18 (-2.74%) ▼|RTX196.39+0.46 (+0.23%) ▲|SBUX107.34+1.33 (+1.25%) ▲|SCHW102.38-0.74 (-0.72%) ▼|SO96.47+0.86 (+0.90%) ▲|SPG219.49+0.72 (+0.33%) ▲|T21.55+0.42 (+1.99%) ▲|TMO528.51+1.46 (+0.28%) ▲|TMUS188.41+0.80 (+0.43%) ▲|TSLA394.76-13.00 (-3.19%) ▼|TXN298.57-12.89 (-4.14%) ▼|UBER74.26-0.28 (-0.38%) ▼|UNH429.09+4.47 (+1.05%) ▲|UNP289.13+2.17 (+0.76%) ▲|UPS112.89+0.42 (+0.37%) ▲|USB62.34-0.07 (-0.11%) ▼|V357.75+8.78 (+2.52%) ▲|VZ42.68+0.56 (+1.33%) ▲|WFC87.67+0.51 (+0.59%) ▲|WMT114.78+0.88 (+0.77%) ▲|XOM144.51+5.63 (+4.05%) ▲|AAPL317.31+1.99 (+0.63%) ▲|ABBV248.00-0.08 (-0.03%) ▼|ABT92.11-1.82 (-1.94%) ▼|ACN138.52+3.29 (+2.43%) ▲|ADBE230.61+6.97 (+3.12%) ▲|AMAT575.39-27.11 (-4.50%) ▼|AMD534.39-23.50 (-4.21%) ▼|AMGN360.45-2.94 (-0.81%) ▼|AMT169.50+0.91 (+0.54%) ▲|AMZN247.31+1.97 (+0.80%) ▲|AVGO384.05-15.92 (-3.98%) ▼|AXP354.43+3.85 (+1.10%) ▲|BA215.51-6.77 (-3.05%) ▼|BAC59.50-0.17 (-0.28%) ▼|BKNG175.80-2.59 (-1.45%) ▼|BLK1,031.56-4.55 (-0.44%) ▼|BMY59.34+1.76 (+3.06%) ▲|BNY151.27-0.65 (-0.43%) ▼|BRK-B496.85+3.14 (+0.64%) ▲|C140.71-0.08 (-0.06%) ▼|CAT931.47-20.94 (-2.20%) ▼|CL93.21+0.97 (+1.05%) ▲|CMCSA23.97+0.40 (+1.70%) ▲|COF203.02+1.50 (+0.74%) ▲|COP112.85+3.81 (+3.49%) ▲|COST926.43+10.18 (+1.11%) ▲|CRM171.22+7.90 (+4.84%) ▲|CSCO119.25-2.06 (-1.70%) ▼|CVS105.90+1.75 (+1.68%) ▲|CVX182.20+5.80 (+3.29%) ▲|DE585.64-1.22 (-0.21%) ▼|DHR200.16+1.11 (+0.56%) ▲|DIS96.00+0.38 (+0.40%) ▲|DUK126.86+1.38 (+1.10%) ▲|EMR135.38-3.50 (-2.52%) ▼|FDX313.74-0.95 (-0.30%) ▼|GD372.78-2.28 (-0.61%) ▼|GE353.42-5.85 (-1.63%) ▼|GEV1,042.60-48.97 (-4.49%) ▼|GILD131.40+1.57 (+1.21%) ▲|GM76.72-1.13 (-1.45%) ▼|GOOG350.67-4.36 (-1.23%) ▼|GOOGL352.51-4.67 (-1.31%) ▼|GS1,045.91-9.27 (-0.88%) ▼|HD337.11-6.19 (-1.80%) ▼|HON222.25-4.17 (-1.84%) ▼|IBM290.23+2.67 (+0.93%) ▲|INTC103.12-6.72 (-6.12%) ▼|INTU289.76+14.80 (+5.38%) ▲|ISRG407.12+0.34 (+0.08%) ▲|JNJ257.77+0.79 (+0.31%) ▲|JPM334.53-1.94 (-0.58%) ▼|KO84.25+0.76 (+0.91%) ▲|LIN524.06-5.73 (-1.08%) ▼|LLY1,181.87-6.71 (-0.56%) ▼|LMT520.68-2.54 (-0.49%) ▼|LOW207.70-3.93 (-1.86%) ▼|LRCX329.92-20.41 (-5.83%) ▼|MA537.70+10.96 (+2.08%) ▲|MCD272.61-1.99 (-0.72%) ▼|MDLZ59.86+1.03 (+1.75%) ▲|MDT83.57-0.30 (-0.36%) ▼|META656.73-12.48 (-1.86%) ▼|MMM157.70+0.18 (+0.11%) ▲|MO71.87+0.08 (+0.11%) ▲|MRK124.03+0.49 (+0.40%) ▲|MS221.09-1.19 (-0.54%) ▼|MSFT390.99+5.89 (+1.53%) ▲|MU937.00-42.30 (-4.32%) ▼|NEE88.38+0.42 (+0.48%) ▲|NFLX73.83+0.46 (+0.63%) ▲|NKE43.76-0.61 (-1.37%) ▼|NOW111.26+3.55 (+3.30%) ▲|NVDA203.53-7.43 (-3.52%) ▼|ORCL131.54-9.10 (-6.47%) ▼|PEP138.49+1.11 (+0.81%) ▲|PFE24.48+0.31 (+1.28%) ▲|PG148.37+1.33 (+0.90%) ▲|PLTR130.04+3.25 (+2.56%) ▲|PM180.19-1.43 (-0.79%) ▼|QCOM183.98-5.18 (-2.74%) ▼|RTX196.39+0.46 (+0.23%) ▲|SBUX107.34+1.33 (+1.25%) ▲|SCHW102.38-0.74 (-0.72%) ▼|SO96.47+0.86 (+0.90%) ▲|SPG219.49+0.72 (+0.33%) ▲|T21.55+0.42 (+1.99%) ▲|TMO528.51+1.46 (+0.28%) ▲|TMUS188.41+0.80 (+0.43%) ▲|TSLA394.76-13.00 (-3.19%) ▼|TXN298.57-12.89 (-4.14%) ▼|UBER74.26-0.28 (-0.38%) ▼|UNH429.09+4.47 (+1.05%) ▲|UNP289.13+2.17 (+0.76%) ▲|UPS112.89+0.42 (+0.37%) ▲|USB62.34-0.07 (-0.11%) ▼|V357.75+8.78 (+2.52%) ▲|VZ42.68+0.56 (+1.33%) ▲|WFC87.67+0.51 (+0.59%) ▲|WMT114.78+0.88 (+0.77%) ▲|XOM144.51+5.63 (+4.05%) ▲|
29 C
New York
Monday, July 13, 2026

Tag: innovation

newssourceFORcompanyinformationcontent1releasesmarket

FDA Approved Anticancer Peptide Drug Conjugate Market Clinical Trials Insight

Global Peptide Drug Conjugate Market USD 1400 Million Opportunity Says Kuick Research In New Study 
Global Peptide Drug Conjugate Market USD 1400 Million Opportunity Says Kuick Research In New Study

Roquette nomme Thierry Fournier au poste de Directeur Général

Roquette nomme Thierry Fournier au poste de Directeur Général

Roquette Appoints Thierry Fournier as Chief Executive Officer

Roquette Appoints Thierry Fournier as Chief Executive Officer

Ormat Technologies Announces Strategic Leadership Changes

RENO, Nev., June 05, 2025 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company, is pleased to announce the appointment of two distinguished executives to its senior management team. These strategic appointments are poised to propel the next phase of the Company’s growth and enhance its operational excellence within the renewable energy sector.

BIOSeedin Innovation Partnering Conference 2025: Spotlight on China’s Biopharma Trailblazers and Global Collaboration

NEWARK, Del., June 5, 2025 /PRNewswire/ -- China's influential innovative drug asset cooperation platform BIOSeedin Innovation Partnering Conference (BIOS), established in 2021, has quickly become one...

FLO Advertising, HYPERVSN, and FIREFLY Unveil the World’s First 3D Holographic Experience Truck on the Las Vegas Strip. — Now Available Nationwide via FIREFLY’s...

Click Here: "View The Experience" LAS VEGAS, June 5, 2025 /PRNewswire/ -- FLO Advertising, the leader in mobile digital billboard innovation, in collaboration with HYPERVSN, the...

Holidaily Brewing Unveils Fruited Blonde Variety Pack Inspired by Fan-Favorite Beer

GOLDEN, Colo., June 05, 2025 (GLOBE NEWSWIRE) -- Holidaily Brewing Company, the nation's leading women-owned and operated gluten-free brewery, is excited to announce the latest addition to its refreshing portfolio: The Fruited Blonde Variety Pack. Inspired by Holidaily’s most popular beer, Favorite Blonde Ale, the variety pack includes three bold and new flavors: Wild Tangerine, Sweet Melon, and Citrusy Passion Fruit.

Unisys Innovation Program Announces the Winners of Its 16th Annual Competition

Top three teams recognized for ideas to create sustainable electric mobility, tumor diagnostics accuracy and remote neurological monitoring BENGALURU, India, and BLUE BELL, Pa.,...

Jersey Jack Pinball and Warner Bros. Discovery Global Consumer Products Announce Harry Potter™ Pinball

CHICAGO, June 5, 2025 /PRNewswire/ -- Jersey Jack Pinball in partnership with Warner Bros. Discovery Global Consumer Products (WBDGCP), is proud to unveil its...

ESA Announces 2025 Recipients of the Interactive Entertainment Impact Awards

Senator Lisa Blunt Rochester (D-Del), Senator Thom Tillis (R-NC) and the Foundation to Eradicate Duchenne recognized as champions of the video game industry WASHINGTON, June 5, 2025...

Plug and Play Expands Semiconductor Ecosystem Program with New Synopsys Collaboration to Accelerate Chip Design Innovation

SUNNYVALE, Calif., June 5, 2025 /PRNewswire/ -- Plug and Play, the world's largest innovation platform based in Silicon Valley, has announced a new collaboration with...

NexusTek Brings Advanced Managed and Professional Services to the Azure Marketplace

Accelerate innovation, maximize cloud value, and satisfy Azure commits DENVER, June 5, 2025 /PRNewswire/ -- NexusTek, a trusted provider of secure, scalable IT solutions, today...

Trustwell’s Julie McGill to Lead Distributor Panel on FSMA 204 at GS1 Connect 2025

Trustwell to moderate expert customer panel at the food industry's premier supply chain conference to discuss distributor-led strategies for traceability, collaboration, and FSMA 204...

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its single-shot chikungunya vaccine, IXCHIQ®, in 304 children. Partially funded by the Coalition for Epidemic Preparedness Innovations (CEPI), with support from the European Union, the trial is intended to support a pivotal Phase 3 study in children, which the Company expects to initiate in the first quarter of 2026, with the objective of extending the product label to this age group.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInnovation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers